Citation: | WANG Chuanxi, DAI Tianyang, HE Kaiming, PU Jiangtao, ZENG Peiyuan, HU Zhi, HAN Fei. Risk factors of perioperative cardiac events in lungcancer patients with high-risk coronary heart disease undergoing pulmonary lobectomy[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 44-49. DOI: 10.7619/jcmp.201907012 |
[1] |
Scott I A, Shohag H A, Kam P C, et al. Preoperative cardiac evaluation and management of patients undergoing elective non-cardiac surgery[J]. Medical Journal of Australia, 2013, 199(10): 667-673. doi: 10.5694/mja13.11066
|
[2] |
Chow C K, Abraham V, Biccard B M, et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery[J]. Jama, 2017, 317(16): 1642-1651. doi: 10.1001/jama.2017.4360
|
[3] |
Devereaux P J, Xavier D, Pogue J, et al. Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery: A Cohort Study[J]. Annals of Internal Medicine, 2011, 154(8): 523-528. doi: 10.7326/0003-4819-154-8-201104190-00003
|
[4] |
Román J A. Comments on the 2014 ESC/ESA Guidelines on Noncardiac Surgery: Cardiovascular Assessment and Management[J]. Revista Espanola De Cardiología, 2014, 67(12): 980-985. doi: 10.1016/j.recesp.2014.10.009
|
[5] |
Kheterpal S, O′Reilly M, Englesbe M J, et al. Preoperative and intraoperative predictors of cardiac adverse events after general, vascular, and urological surgery[J]. Anesthesiology, 2009, 110(1): 58-66. doi: 10.1097/ALN.0b013e318190b6dc
|
[6] |
Smilowitz N R, Berger J S. Perioperative management to reduce cardiovascular events[J]. Circulation, 2016, 133(11): 1125-1130. doi: 10.1161/CIRCULATIONAHA.115.017787
|
[7] |
Devereaux P J, Sessler D I. Cardiac complications in patients undergoing major noncardiac surgery[J]. N Engl J Med, 2015, 373(23): 2258-2269. doi: 10.1056/NEJMra1502824
|
[8] |
Hillis L D, Smith P K, Anderson J L. American College of Cardiology Foundation/American Heart Association task force on practice guidelines 2011. ACCF/AHA guideline for coronary artery bypass graft surgery[J]. Circulation, 2011, 124(65): e652-e735. http://www.onacademic.com/detail/journal_1000037799058110_1aa6.html
|
[9] |
Alcock R F, Kouzios D, Naoum C, et al. Perioperative myocardial necrosis in patients at high cardiovascular risk undergoing elective non-cardiac surgery[J]. Heart, 2012, 98(10): 792-798. doi: 10.1136/heartjnl-2011-301577
|
[10] |
Bateman B T, Schumacher H C, Wang S, et al. Perioperative acute ischemic stroke in noncardiac and nonvascular surgery: incidence, risk factors, and outcomes[J]. Anesthesiology, 2009, 110(2): 231-238. doi: 10.1097/ALN.0b013e318194b5ff
|
[11] |
Ye Z, Lu H, Su Q, et al. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis[J]. Plos One, 2017, 12(2): e0171682-e0171689. doi: 10.1371/journal.pone.0171682
|
[12] |
Ankle Brachial Index Collaboration, Fowkes F G, Murray G D, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis[J]. JAMA, 2008, 300(2): 197-208. doi: 10.1001/jama.300.2.197
|
[13] |
Hansen P W, Gislason G H, Jørgensen M E, et al. Influence of age on perioperative major adverse cardiovascular events and mortality risks in elective non-cardiac surgery[J]. European Journal of Internal Medicine, 2016, 35(25): 55-59. http://www.sciencedirect.com/science/article/pii/S0953620516301649
|
[14] |
陈志彦, 徐明, 高炜. 高血压血管重构的力学调控机制研究进展[J]. 生理科学进展, 2017, 48(1): 77-81. doi: 10.3969/j.issn.0559-7765.2017.01.020
|
[15] |
Barbarossa G, Renzi A, D′Erasmo L, et al. The relation between glycemic control and HDL-C in type 2 diabetes: a preliminary step forward[J]. Diabetes Research & Clinical Practice, 2014, 104(1): e26-e28. http://europepmc.org/abstract/med/24468098
|
[16] |
Kim S E, Park D G, Lee J H, et al. Utility of B-Type Natriuretic Peptide for Predicting Perioperative Cardiovascular Events in Patients Without History of Cardiovascular Disease Undergoing Major Non-Cardiac Surgery[J]. Korean Circulation Journal, 2011, 41(1): 11-15. doi: 10.4070/kcj.2011.41.1.11
|
[17] |
刘子嘉, 许力, 于春华, 等. 高龄冠心病患者行非心脏手术的围术期心脏事件危险因素分析[J]. 中国医学科学院学报, 2015, 37(5): 541-548. doi: 10.3881/j.issn.1000-503X.2015.05.009
|
[18] |
Joergensen M E, Torp-Pedersen C, Gislason G H, et al. stroke is an important perioperative risk factor and predicts major adverse cardiovascular events after elective surgery[J]. Journal of the American College of Cardiology, 2013, 61(10): E1363-E1363. doi: 10.1016/S0735-1097(13)61363-7
|
[19] |
Sakuma L M, Machado F S, Martins M d e A. Independent association of smoking with postoperative cardiac events and thirty-day mortality[J]. Arq Bras Cardiol, 2010, 94(5): 625-632. doi: 10.1590/S0066-782X2010005000022
|
[20] |
Reeves G K. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK[J]. 2013, 381(9861): 133-141.
|
[21] |
Baigent C, Landray M J, Reith C, et al. Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)[J]. American Journal of Kidney Diseases, 2016, 68(3): 371-380. doi: 10.1053/j.ajkd.2016.02.052
|
[22] |
Lee J S, Chang P Y, Zhang Y, et al. Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study[J]. Diabetes Care, 2017, 6(4): 529-537.
|
[23] |
Nwobodo N, Anyaehie U B, Nwobodo E D, et al. Evaluation of the ratios T-C/HDL-C and LDL-C/HDL-C as useful summary estimates of coronary heart disease risk in Enugu, Nigeria[J]. Oriental Journal of Chemistry, 2008, 24(1): 49-52. http://www.researchgate.net/publication/301765939_Evaluation_of_the_ratios_T-CHDL-C_and_LDL-CHDL-C_as_useful_summary_estimates_of_coronary_heart_disease_risk_in_Enugu_Nigeria
|
[24] |
Jr S S, Allen J, Blair S N, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute[J]. Journal of the American College of Cardiology, 2006, 47(10): 2130-2139. doi: 10.1016/j.jacc.2006.04.026
|
[25] |
Joseph J, Velasco A, Hage F G. Guidelines in review: Comparison of ESC and ACC/AHA guidelines for the diagnosis and management of patients with stable coronary artery disease[J]. Journal of nuclear?cardiology: official publication of the American Society of Nuclear Cardiology, 2018, 25(2): 509-515. doi: 10.1007/s12350-017-1055-0
|
[26] |
Ye Z, Lu H, Su Q, et al. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis[J]. Plos One, 2017, 12(2): e0171682-e0171689. doi: 10.1371/journal.pone.0171682
|
[27] |
Liang D, Zhang Q, Yang H, et al. Anti-Oxidative Stress Effect of Loading-Dose Rosuvastatin Prior to Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: A Prospective Randomized Controlled Clinical Trial[J]. Clinical Drug Investigation, 2014, 34(11): 773-781. doi: 10.1007/s40261-014-0231-0
|
[28] |
王海燕, 朱志远, 任燕妮, 等. 老年冠心病患者非心脏手术后主要心血管事件发生情况及其危险因素分析[J]. 山东医药, 2015, 55(46): 64-65. doi: 10.3969/j.issn.1002-266X.2015.46.028
|